to main page send e-mail site map
 

 

           

What is the First 100 Study?

Track the symptoms of Parkinson's with a study that
introduces holistic interventions and natural treatments

to restore health.

Describe the idea behind the First 100 Study.

Current treatments for Parkinson's have troublesome
side effects and are unable to address the underlying
causes of Parkinsons Disease. There has to be a better way.

Let's do a three year study to evaluate the effect of
holistic treatments. Anecdotal evidence reveals that
when people with Parkinson's Disease eat healthy food,
exercise, hydrate their cells, reduce stress, release
trauma and eliminate toxins, they feel better.

Let's :

  • Acknowledge that the symptoms of Parkinson's

           are caused by a variety of interrelated factors.

  • Assume that no single treatment or intervention

           can "cure" Parkinson's.

  • Expose holistic care to a study population of

          100 persons for 3 years.

  • Assert that the body has the wisdom to heal itself

          when it is given proper nourishment and support.

  • Do a pre-post study that meticulously tracks symptoms.
  • Document the timing of recovery.
  • Select holistic treatments that are inspired by the

          experiences of people with Parkinson's who have

          been able to get relief from their symptoms.

  • Offer study subjects treatments that are specific

          to their individual health needs.

  • Break free of the constraints of an antiquated

          scientific approach that evaluates the effect of a

          single treatment, holding "constant" everything else.

  • Launch a revolutionary approach to scientific discovery.

The static research paradigm that is required to fund

research does not serve the needs of anyone who is

affected by the disease that is being studied.

I propose we do it differently. Hypothesis of the First 100

study:  When treated holistically, persons with Parkinson's

will experience a significant relief from symptoms.

Some people who have had Parkinson's are symptom

free today. It was not easy. It was not quick, but it has been

possible for some people. Let's set out to examine whether

recovery is possible for anyone using a holistic approach.

What problem does this proposal address?

Relying on a conventional approach to scientific inquiry,
everyone with Parkinson's will be dead before any genuine
progress is made. Science is painfully slow and meticulous.
It is not intended or designed to help the living.

Conventional thinking in science evaluates the impact of a

single factor (like a drug or surgery). Parkinson's is clearly

a multi-faceted condition.

Evaluation of any one treatment is bound to have a miniscule

impact. This has in fact been the case with existing studies

of Parkinson's.

The First 100 study proposed here would never pass through

a university review process. No single factor is being evaluated

or "controlled."

There will never be an organization – government or private –

that has a vested interest in funding such a study. Who benefits

from the discovery that the body can heal itself other than the

patient? No one other than the patient.


If this idea becomes a reality, who would benefit the most

and why?

Persons with Parkinson's. Discoveries are reported in

real time, not years after the study is concluded. Information

about treatments that show promise are disseminated

through the internet. Anyone with Parkinson's anywhere in

the world can learn how they too can get relief from their

symptoms. Approaches that do not prove beneficial are

identified and disclosed, saving countless individuals

needless expense.

Researchers. Instead of being tied to the "slow as molasses"

approach to scientific discovery, researchers determine what

really makes a difference as the study project unfolds. There is a

limitless potential to identify the underlying causes of Parkinson's

and the treatments that can heal it.

Study volunteers and health care practitioners. First 100 study

volunteers who have Parkinson's receive the benefits from intensive

support and therapies offered by multi-disciplinary teams of health

care providers. Health care practitioners also learn which treatments

offer the most help to individuals with Parkinson's.

Describe the optimal outcome from the First 100 Study

Many people believe that Parkinson's is a progressively

degenerative disease. Once a person is diagnosed, this

long standing belief says that symptoms are destined to

deteriorate. The optimal outcome of the study will show that

this belief is blatantly false.

Quantitative and qualitative assessment instruments evaluate

the progress of each study subject. Standard research

instruments from the Parkinson's literature are administered

before the treatments begin. Qualitative assessments include

extensive interviews and videos of motor functions. All pre-test

symptoms are thoroughly and systematically recorded.
Using the same quantitative and qualitative instruments,

follow-up evaluations are administered periodically over the

course of the three year study. Every aspect of the individual's

condition is tracked.

Research on Parkinson's provides extensive baseline evidence

on the "natural" progression of symptoms. Meta-analytic

techniques are used to derive estimates for the disease

progression of people with Parkinson's who do not receive

the benefits of a holistic intervention.

First Step

I am currently recruiting a researcher to develop a full fledged
proposal for the first 100 Study. Once I locate the appropriate
person, I will solicit tax deductible contributions to fund the
proposal development process. The First 100 Study will be
underwritten by the support of individuals interested in finding

the answers for Parkinson's. .